Media Pack
News

Current Edition

Volume 7 Issue 3

Upcoming Events

 

Advertisement

 
 
 
 
Next-generation Proximity-based Luminescence Assays & CRISPR/Cas9 Genome Engineering and nanoBRET
Volume 7 Issue 3

Next-generation Proximity-based Luminescence Assays & CRISPR/Cas9 Genome Engineering and nanoBRET

Bioluminescence resonance energy transfer (BRET) is a technology often used to probe the proximity of molecules within live cells. BRET assays have many applications...
30 September 2024 Volume 7 Issue 3 | Application Notes
Continue Reading →
Meeting Drug Development Challenges:An Insider’s View on CDMO Services for Biologics
Volume 7 Issue 3

Meeting Drug Development Challenges:An Insider’s View on CDMO Services for Biologics

As industry leaders and customers from across the globe gathered to discuss the latest trends and challenges in drug development and manufacturing at this year’s BIO...
30 September 2024 Volume 7 Issue 3 | Application Notes
Continue Reading →
Unlocking Early Drug Development Potential with CDMO Expertise
Volume 7 Issue 3

Unlocking Early Drug Development Potential with CDMO Expertise

Early-phase drug product development and manufacturing are crucial steps in transforming promising drug candidates into viable, life-changing therapies. In the fast-...
30 September 2024 Volume 7 Issue 3 | Application Notes
Continue Reading →
NK Cell Therapy – An IP Update
Volume 7 Issue 3

NK Cell Therapy – An IP Update

Advances in CAR-T cell therapy have carved a path for improved treatments in the field of oncology, in particular haematological cancers. In 2018, the European Medic...
30 September 2024 Volume 7 Issue 3 | Application Notes
Continue Reading →
Volume 7 Issue 3

Bridging the Care Gap for Children with Medical Complexity

Children with medical complexity (CMC) live with congenital or acquired multi-system diseases, severe neurologic conditions with marked functional impairment, and/or...
30 September 2024 Volume 7 Issue 3 | Current Features
Continue Reading →
Volume 7 Issue 3

Breaking Down Barriers for Postgraduate Researchers

How truly open access publishing models improve project outcomes for postgraduate research students One of the hardest things about starting a research project is...
30 September 2024 Volume 7 Issue 3 | Current Features
Continue Reading →
Current Features

Leveraging Simplicity to Enhance Efficiency for First-in-human Clinical Trials

It is well-known that going from drug discovery to commercialisation takes, on average, 10–15 years and poses significant costs – approximately $2.6 billion when R&a...
30 September 2024 Current Features | Volume 7 Issue 3
Continue Reading →
Volume 7 Issue 3

CellShip: An Ambient Temperature Transport and Short-term Storage Medium for Mammalian Cell Cultures

Cell culture is fundamental to many research and industrial processes, but traditional transport methods are fraught with challenges. Cryopreservation, the most comm...
30 September 2024 Volume 7 Issue 3 | Current Features
Continue Reading →
Volume 7 Issue 3

AI in Drug Discovery: High-throughput SPR Boosts Breakthroughs

Artificial intelligence (AI) is revolutionising drug discovery, enabling scientists to identify novel therapeutic candidates in a fraction of the time it once requir...
30 September 2024 Volume 7 Issue 3 | Current Features
Continue Reading →
Volume 7 Issue 3

Small Molecule Microarrays: An established Hit-identification Technique with New Potential for Challenging Targets.

Small molecule microarray (SMM) is a well-established method for identifying small molecule (SM) binding interactions with a diverse range of target types. It has pr...
30 September 2024 Volume 7 Issue 3 | Current Features
Continue Reading →
 
 
 
 
IBI-white.png

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Facebook Linkedin
Bio Pharmaceutical Media © 2024, All Rights Reserved – Powered by Teksyte